Literature DB >> 20110596

Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex.

Virginia Martín1, Noemí Fabelo, Gabriel Santpere, Berta Puig, Raquel Marín, Isidre Ferrer, Mario Díaz.   

Abstract

Lipid rafts are membrane microdomains intimately associated with cell signaling. These biochemical microstructures are characterized by their high contents of sphingolipids, cholesterol and saturated fatty acids and a reduced content of polyunsaturated fatty acids (PUFA). Here, we have purified lipid rafts of human frontal brain cortex from normal and Alzheimer's disease (AD) and characterized their biochemical lipid composition. The results revealed that lipid rafts from AD brains exhibit aberrant lipid profiles compared to healthy brains. In particular, lipid rafts from AD brains displayed abnormally low levels of n-3 long chain polyunsaturated fatty acids (LCPUFA, mainly 22:6n-3, docosahexaenoic acid) and monoenes (mainly 18:1n-9, oleic acid), as well as reduced unsaturation and peroxidability indexes. Also, multiple relationships between phospholipids and fatty acids were altered in AD lipid rafts. Importantly, no changes were observed in the mole percentage of lipid classes and fatty acids in rafts from normal brains throughout the lifespan (24-85 years). These indications point to the existence of homeostatic mechanisms preserving lipid raft status in normal frontal cortex. The disruption of such mechanisms in AD brains leads to a considerable increase in lipid raft order and viscosity, which may explain the alterations in lipid raft signaling observed in AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110596     DOI: 10.3233/JAD-2010-1242

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  85 in total

Review 1.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

Authors:  Noemí Fabelo; Virginia Martín; Gabriel Santpere; Raquel Marín; Laia Torrent; Isidre Ferrer; Mario Díaz
Journal:  Mol Med       Date:  2011-06-22       Impact factor: 6.354

3.  Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action.

Authors:  Karima Bettayeb; Nassima Oumata; Yuanyuan Zhang; Wenjie Luo; Victor Bustos; Hervé Galons; Paul Greengard; Laurent Meijer; Marc Flajolet
Journal:  FASEB J       Date:  2012-09-12       Impact factor: 5.191

4.  Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

Authors:  Robin B Chan; Tiago G Oliveira; Etty P Cortes; Lawrence S Honig; Karen E Duff; Scott A Small; Markus R Wenk; Guanghou Shui; Gilbert Di Paolo
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

5.  Metabolic Alterations and the Protective Effect of Punicalagin Against Glutamate-Induced Oxidative Toxicity in HT22 Cells.

Authors:  Kavitha Pathakoti; Lavanya Goodla; Manjunath Manubolu; Tewin Tencomnao
Journal:  Neurotox Res       Date:  2017-01-09       Impact factor: 3.911

6.  Highlighting anatomical sub-structures in rat brain tissue using lipid imaging.

Authors:  Alice M Delvolve; Benoit Colsch; Amina S Woods
Journal:  Anal Methods       Date:  2011-08-01       Impact factor: 2.896

Review 7.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

8.  Membrane-Associated Effects of Glucocorticoid on BACE1 Upregulation and Aβ Generation: Involvement of Lipid Raft-Mediated CREB Activation.

Authors:  Gee Euhn Choi; Sei-Jung Lee; Hyun Jik Lee; So Hee Ko; Chang Woo Chae; Ho Jae Han
Journal:  J Neurosci       Date:  2017-08-03       Impact factor: 6.167

Review 9.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

10.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.